EVADEREFighting Antimicrobial Resistance

Fighting Antimicrobial Resistance
Through Next-Generation Vaccines

(Enhanced VAccines DEsign against antimicrobial REsistance)

Medicinal Chemistry · Biological Sciences · Immunology · Medical Sciences · Vaccinology

About the Project

EVADERE (Enhanced VAccines DEsign against antimicrobial REsistance) is an innovative European Training Network that will provide high-level training in vaccinology to 15 high-achieving, creative Doctoral Candidates (DCs), and equip them with a wide range of transferrable skills for thriving careers in vaccine research within academia and industry. EVADERE is built on successful collaborative research (two MSCA-ETN projects, BactiVax & GlycoVax) , and represents a step change from conventional protein vaccine development approach, in that it will extensively employ structural biology and conjugation chemistry to enhance antigen immunogenicity and improve adjuvant function, and in that way generate entirely novel therapeutic and prophylactic vaccine formulations ready for translational advancement towards clinical phase of testing.

This network comprises 14 Principal Investigators with expertise in medicinal chemistry, glycochemistry, vaccinology, proteomics, medicine, microbiology, biochemistry, immunology, structural biology, from 8 European countries and two companies which will collectively train DCs in entrepreneurship, commercial vaccine development and bioprocessing.

Learn more about the project ↓

Selection process update

The recruitment process has now been completed, and all Doctoral Researcher positions within the EVADERE project have been filled.

All selected candidates have been contacted directly by the relevant Principal Investigators. Therefore, applicants who have not received any communication by email have not been selected.

Due to the high number of applications received, we regret that it was not possible to provide individual feedback to every applicant. We apologise for any inconvenience this may cause.

We sincerely thank all applicants for their interest in the EVADERE project and for the time and effort dedicated to their applications.

We wish all applicants every success in their future research and professional careers.

Latest News

View all news & updates →

Meet the Team

Principal Investigators Meet the 14 Principal Investigators → Doctoral Candidates Meet the 15 Doctoral Candidates →

Project Description

Training in vaccines targeting antimicrobial resistance

Certain microbes can survive antimicrobial treatment. Vaccines to combat the phenomenon of antimicrobial resistance (AMR) are urgently needed. Supported by the Marie Sklodowska Curie Actions programme, the EVADERE project aims to train 15 PhD students in the research and development of vaccines against AMR. The training will cover patentable antigens, adjuvants, and novel delivery systems. The purpose is to ensure that the participants are academically and industrially ready for the next stage of their research careers in vaccines, while also contributing to the advancement of equality and inclusion.

Objective

EVADERE (Enhanced VAccines DEsign against antimicrobial REsistance) is a multidisciplinary consortium of 14 interna-tionally recognised experts (12 from academia and 2 from industry) from 9 European countries who will provide 15 doctor-al candidates (DCs) with high-quality inter-sectoral training in discovery and development of vaccines targeting antimicro-bial resistance (AMR) based on innovative antigens, adjuvants, and delivery methods. Trainees will acquire a broad range of transferable skills to underpin their resilience for future careers in vaccine research within academia and industry respecting gender and equality.